Beware These 10 Biopharma “High-Beta Bombs”
Avoid the market’s most volatile stocks, advises the author of today’s article. In fact, he refers to the market’s top 10% or top 20% most…
Market Conditions
These Biotech Stocks Could Get “Let Out Of The Cage” This Year
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
With Coronavirus Vaccines Still In Development, These 3 Stocks Are Poised To Soar This Year (With Some Risk)
In 2021, “The big stories…could come from vaccines that haven’t made it to market yet. It’s possible that the stocks of the companies developing these…
More Outperformance Ahead For These 2 “Class of 2018” Biotech Stocks?
The two biotech stocks highlighted in today’s article both made their public market debuts in 2018 – and both have performed very well for investors…
The Best Options Strategy For The Moment
“One of the biggest advantages of options trading is that you can make money in any market. All you need is the right strategy to…
The Birth Of “The Biotech Tourist”
“The search for a Covid-19 cure and an end to global shutdowns has created a new type of investor in health-care stocks: the biotech tourist,”…
7 “Bright Spot” Biotech Stocks In The Spotlight
“With the scramble for viral and antibody testing kits, and the ultimate goal of finding a vaccine for Covid-19, many biotech companies are suddenly in…
Upside Potential In The Pipelines: 3 “Strong Buy” Biotech Stocks To Consider
Some sectors are holding up much better than others in the current market environment – and offering compelling plays in the process. One of those…
3 “Compelling” Biotech Stocks With Small Price Tags And Big Upside Potential
In assessing the current market environment, the author of today’s article notes that “it becomes apparent that there’s an opportunity for those able to take…
Buy Tomorrow’s Dividend Aristocrats (Such As These 3 Stocks) At A Bargain Today
Dividend Aristocrats are great, but as the author of today’s article notes, “everyone already knows these firms are great. And as a result, their stocks…